导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.03% | 104/639 |
| 近一周 | -0.28% | 434/660 |
| 近一月 | 0.15% | 64/656 |
| 近一季 | - | 384/654 |
| 近半年 | 5.42% | 159/653 |
| 近一年 | 9.69% | 71/635 |
| 近两年 | 15.73% | 133/613 |
| 近三年 | 10.23% | 282/538 |
| 成立以来 | 29.33% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
1.84% 196/1341 |
0.82% 851/1366 |
7.60% 186/1361 |
- - |
| 2024 | 4.62% 801/1373 |
2.58% 160/1403 |
1.84% 267/1402 |
0.38% 1166/1374 |
-0.23% 1189/1373 |
| 2023 | -3.72% 1038/1401 |
3.14% 150/1367 |
-3.14% 1292/1388 |
0.02% 322/1403 |
-3.65% 1345/1401 |
| 2022 | -4.84% 789/1336 |
-6.56% 982/1128 |
5.27% 65/1307 |
-4.20% 1132/1325 |
0.99% 171/1336 |
| 2021 | 3.37% 480/1165 |
1.70% 88/633 |
6.10% 38/921 |
-4.30% 892/1070 |
0.09% 954/1163 |
| 2020 | 19.23% 72/650 |
-0.37% 233/336 |
6.77% 62/504 |
8.02% 48/587 |
3.76% 306/675 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)C | 1.8048 | 37.74% |
| 泰信现代服务业混合 | 2.0450 | 32.88% |
| 易方达标普生物科技人民币A | 1.7298 | 28.02% |
| 永赢高端装备智选混合发起A | 1.1625 | 27.65% |
| 永赢高端装备智选混合发起C | 1.1467 | 27.52% |
| 金信稳健策略混合A | 2.2741 | 23.08% |
| 金信精选成长混合A | 1.6584 | 22.49% |
| 金信精选成长混合C | 1.6361 | 22.31% |
| 东方人工智能主题混合C | 1.5534 | 22.12% |
| 金信行业优选混合发起式A | 2.7474 | 21.61% |
| 汇添富稳健增长混合A VS. () |